For citations:
Petrov V.I., Ryazanova A.Y., Nekrasov D.A., Svinukhov V.I., Privaltseva N.S. Safety of Therapy with Tocilizumab and Other Interleukin Inhibitors. Safety and Risk of Pharmacotherapy. 2022;10(1):34-47. (In Russ.) https://doi.org/10.30895/2312-7821-2022-10-1-34-47
Email this article 